Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/VISTAGEN-THERAPEUTICS-INC-27506590/news/Vistagen-Initiates-PALISADE-3-Phase-3-Study-of-Fasedienol-for-the-Acute-Treatment-of-Social-Anxiety-46329551/?utm_source=whatsapp&utm_medium=social&utm_campaign=share